The global market for PVA is vast and continues to expand; its consumption structure is closely correlated with the level of economic development in various regions. In industrialized nations, demand for PVA remains stable in traditional sectors such as adhesives, papermaking, and construction. Conversely, in emerging markets-particularly within the Asia-Pacific region-consumption has witnessed significant growth in sectors such as textiles and packaging. Pharmaceutical-grade and high-performance PVA products represent a key direction for high-value-added development within the industry.
Depending on their intended application, Polyvinyl Alcohol (PVA) products must adhere to specific quality standards. Common standards include the Chinese Pharmacopoeia (CP2020), the United States Pharmacopeia (USP32), and various chemical industry standards. Key control parameters typically include:
These primary control parameters encompass appearance, viscosity, degree of alcoholysis/hydrolysis, pH value, loss on drying, residue on ignition, and heavy metals. Specifically, the product typically appears as a white solid powder; viscosity corresponds to specific ranges based on the degree of polymerization (e.g., 4–65 mPa·s); the degree of alcoholysis/hydrolysis is required to fall within ±1% of the labeled value; the pH value typically ranges from 5 to 8; loss on drying is limited to ≤5.0%; residue on ignition ranges from ≤0.5% to 2.0%; and heavy metal content is restricted to ≤10 ppm (a requirement for pharmaceutical-grade products).
Pharmaceutical-grade PVA is subject to more stringent requirements regarding impurity control and biological safety. Possessing excellent biocompatibility, pharmaceutical-grade Polyvinyl Alcohol is widely utilized in biomedical fields, serving as a carrier for pharmaceuticals, a component in medical dressings, and a scaffold for tissue engineering. Furthermore, it finds application in the development of dressings for infected wounds, scaffolds for bone tissue regeneration, and therapeutic interventions for cardiovascular diseases.